Back

Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Acute and anticoagulation Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Jackson King

Spokane (United States of America)

10 More presentations in this session

Presentation thumbnail
Determinants of the use of direct oral anticoagulants in acute pulmonary thromboembolism in argentina
Mr M. Bernal (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Predictors for not initiating anticoagulant treatment after incident venous thromboembolism: a Danish nationwide study
Doctor I. Albertsen (Aalborg, DK)
Abstract
Presentation thumbnail
Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results
Doctor N. Vorobyeva (Moscow, RU)
Abstract Slides
Presentation thumbnail
Early versus delayed oral anticoagulation in patients with acute pulmonary embolism: determinants and outcome.
Professor C. Becattini (Perugia, IT)
Abstract
Presentation thumbnail
Patterns of extended apixaban treatment for unprovoked venous thromboembolism in routine clinical practice
Doctor X. Luo (Groton, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Acute and anticoagulation

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources